Cell and Gene Therapy Catapult; CEVEC Pharmaceuticals GmbH; Cobra Biologics Ltd. Creative Biogene; FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
https://www.google.com/url?rct=j&sa=t&url=https://restonrecorder.ca/news/viral-vector-manufacturing-market-revenue-strategy-forecast-report-2022-to-2030/619024/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw3Q6kMs4Qbd6IuzrG4JkCwI
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.